Octreotide Acetate Kit
NDC 0480-9259
Product Information
Octreotide Acetate is a ANDA-approved product labeled by Teva Pharmaceuticals, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a kit for intramuscular administration. This product entry covers the primary NDC 0480-9259 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 0480-9259?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- Octreotide Acetate (NDC 0480-9258)
- OCTREOTIDE ACETATE (UNII: 75R0U2568I)
- OCTREOTIDE (UNII: RWM8CCW8GP) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- Octreotide Acetate (NDC 0480-9258)
- LACTIC ACID, DL- (UNII: 3B8D35Y7S4)
- MANNITOL (UNII: 3OWL53L36A)
- DILUENT (NDC 0480-9263)
- CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)
- MANNITOL (UNII: 3OWL53L36A)
- POLOXAMER 188 (UNII: LQA7B6G8JG)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 898589 - octreotide LAR 20 MG Injection
- RxCUI: 898589 - octreotide 20 MG Injection
- RxCUI: 898589 - octreotide (as octreotide acetate) 20 MG Injection
- RxCUI: 898601 - octreotide LAR 30 MG Injection
- RxCUI: 898601 - octreotide 30 MG Injection
* Please review the full disclaimer at the bottom of this page.